Hmmm. Latest version of sinusitis are not responding to normal doses. Several co-workers have had two to three week infections that only responded to repeated courses. Seems “the bridge too far” is already working its way through the population. Ugh!
The findings represent an opportunity to reduce unnecessary use of the drugs.